Maravai LifeSciences Holdings Inc (MRVI)
10.46
+0.62
(+6.30%)
USD |
NASDAQ |
May 10, 16:00
10.46
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Enterprise Value: 1.628B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.628B |
| May 08, 2024 | 1.499B |
| May 07, 2024 | 1.511B |
| May 06, 2024 | 1.518B |
| May 03, 2024 | 1.512B |
| May 02, 2024 | 1.490B |
| May 01, 2024 | 1.439B |
| April 30, 2024 | 1.410B |
| April 29, 2024 | 1.364B |
| April 26, 2024 | 1.344B |
| April 25, 2024 | 1.328B |
| April 24, 2024 | 1.340B |
| April 23, 2024 | 1.346B |
| April 22, 2024 | 1.300B |
| April 19, 2024 | 1.291B |
| April 18, 2024 | 1.332B |
| April 17, 2024 | 1.348B |
| April 16, 2024 | 1.402B |
| April 15, 2024 | 1.398B |
| April 12, 2024 | 1.437B |
| April 11, 2024 | 1.462B |
| April 10, 2024 | 1.463B |
| April 09, 2024 | 1.451B |
| April 08, 2024 | 1.366B |
| April 05, 2024 | 1.377B |
| Date | Value |
|---|---|
| April 04, 2024 | 1.453B |
| April 03, 2024 | 1.464B |
| April 02, 2024 | 1.451B |
| April 01, 2024 | 1.463B |
| March 31, 2024 | 1.472B |
| March 28, 2024 | 1.472B |
| March 27, 2024 | 1.460B |
| March 26, 2024 | 1.429B |
| March 25, 2024 | 1.449B |
| March 22, 2024 | 1.481B |
| March 21, 2024 | 1.402B |
| March 20, 2024 | 1.406B |
| March 19, 2024 | 1.383B |
| March 18, 2024 | 1.375B |
| March 15, 2024 | 1.341B |
| March 14, 2024 | 1.289B |
| March 13, 2024 | 1.368B |
| March 12, 2024 | 1.346B |
| March 11, 2024 | 1.348B |
| March 08, 2024 | 1.337B |
| March 07, 2024 | 1.274B |
| March 06, 2024 | 1.286B |
| March 05, 2024 | 1.263B |
| March 04, 2024 | 1.329B |
| March 01, 2024 | 1.327B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
939.63M
Minimum
Nov 08 2023
7.229B
Maximum
Aug 20 2021
3.256B
Average
3.058B
Median
Jan 14 2021
Enterprise Value Benchmarks
| ModivCare Inc | 1.477B |
| Dyadic International Inc | 35.86M |
| Enveric Biosciences Inc | 4.422M |
| Monopar Therapeutics Inc | 5.146M |
| SeaStar Medical Holding Corp | 41.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.08M |
| Revenue (Quarterly) | 64.18M |
| Total Expenses (Quarterly) | 84.25M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 40.27% |
| Profit Margin (Quarterly) | -18.82% |
| Earnings Yield | -9.46% |
| Normalized Earnings Yield | -47.68 |